tryptamine therapeutics (asx:typ) | webinar with jason carroll | 28/08/24
Published 2 months ago • 255 plays • Length 57:00Download video MP4
Download video MP3
Similar videos
-
0:32
ceo jason carroll's increasing stake in tryptamine therapeutics #typ #asx #asxinterview #ceo #stocks
-
15:48
jason carroll, ceo of tryptamine therapeutics ltd [asx:typ] presents at techknow 2024 (july 31)
-
0:52
ceo jason carroll on why typ could be a game-changer in #neuropsychiatry treatments in australia
-
0:58
#typ ceo jason carroll on why the data spells out the need for new treatments in #neuropsychiatry
-
13:41
tryptamine therapeutics launches on asx with innovative psilocin formulation
-
8:03
pain relief: from physiology to neurology | sadhguru @ harvard medical school
-
30:37
what is the therapeutic potential of psychedelics? tomás páleníček
-
48:56
psychedelics and plasticity-promoting neurotherapeutics - uc davis psychedelic summit 2023
-
4:50
2024 techknow invest roadshow conference q&a with jason carroll of tryptamine therapeutics
-
0:57
tryp therapeutics successfully completes maiden dosing of iv-infused psilocin in a world-first #typ
-
1:08
jason carroll just bought 9 8% more shares in hiremii limited asxhmi
-
1:45:31
lecture on the frontiers of science and therapy of psilocybin
-
1:57
stocks of the hour: arizona lithium, apollo minerals, sezzle
-
6:52
tryp therapeutics: unlocking the potential of psychedelics for chronic pain
-
2:28:13
microbiome - listen to your gut
-
57:25
ifst webinar: the gut microbiome : a whole new world to explore
-
1:26:50
webinar: psychedelics for psychiatrists - at the forefront of a paradigm shift for mental-illness
-
16:18
mindful medicine: charles paccione at tedxslc
-
5:13
the assay tv - michael parker, executive director, solis minerals (asx:slm)